Colazal (KOL-a-zal), a new drug for ulcerative colitis

Salix Pharmaceuticals is now marketing Colazal (KOL-a-zal), a new drug for ulcerative colitis.

Colazal (balsalazide) is broken down by bacteria in the colon to release mesalamine and an inert compound.

Asacol and Pentasa are delayed-release mesalamine products that rely on the emptying rate of the stomach and pH of the GI tract. Some is released before reaching the colon and is absorbed systemically.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote